Suspension of Negatively Charged Microspheres (NCM) A unique technology for wound management specially aimed to reactivate the healing process. Medical Device Class IIb with CE Mark, manufactured by Praxis Pharmaceutical in Spain, under the ISO 13485 and distributed through partners in different markets.
PolyHeal Micro is indicated for the treatment of ulcers of different etiologies and stagnant hard to heal wounds, including exposed bones and tendons, such as: - Venous and arterial leg ulcers, diabetic foot ulcers, pressure ulcers; - Drainage, post-traumatic, post-surgical wounds; - Ulcers in co-morbid patients.
PolyHeal Micro reactivates the healing process and produces consistent granulation tissue suitable for skin graft (even in wounds with exposed bones and tendons) and closure by epithelization.
Single use, sterile suspension that is easy to apply by physicians, nurses, patients family caregivers or the patients themselves, both in an in-patient or out-patient setting.
We are currently looking for direct distributors with the capacity to reach hospital channel and outpatient health care centers.
Praxis Pharmaceutical is a company specialized in the commercial development of pharmaceutical products and medical devices for the advanced treatment of chronic wounds, based in Madrid (Spain).
At Praxis Pharmaceutical we are committed to the internationalization of PolyHeal Micro as one of our long-term growth engines. Proof of this are our alliances with business partners to open new markets and have a presence in the 5 continents.